Diabetes Therapy Podcast: ATTD Conference Highlights Sufyan HussainTim Street Editorial Open access 25 July 2020 Pages: 2195 - 2206
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver? David M. WilliamsMarc Evans Review Open access 27 August 2020 Pages: 2207 - 2219
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies David M. WilliamsMarc Evans Review Open access 03 September 2020 Pages: 2221 - 2235
Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach João P. FerreiraFrancisco AraújoSílvia Alão Original Research Open access 11 July 2020 Pages: 2237 - 2255
Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2) Sujoy GhoshMangesh TiwaskarVijay Panikar Original Research Open access 11 August 2020 Pages: 2257 - 2268
The Correlation Between RDW, MPV and Weight Indices After Metabolic Surgery in Patients with Obesity and DM/IGR: Follow-Up Observation at 12 Months Li ZhouShibo LinHongwen Zhou Original Research Open access 13 August 2020 Pages: 2269 - 2281
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study Mauro RagoneseMonica LarosaAntonio Nicolucci Original Research Open access 19 August 2020 Pages: 2283 - 2298
Discontinuing Aspirin After Short Term Use Versus Continuous Use with a P2Y12 Inhibitor for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Meta-analysis Qiang WangKeping YangPravesh Kumar Bundhun Original Research Open access 25 August 2020 Pages: 2299 - 2311
Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial Li WangXiangyang LiuQiuhe Ji Original Research Open access 27 August 2020 Pages: 2313 - 2328
Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies Jian KuangJiankun ZhuQuanmin Li Original Research Open access 28 August 2020 Pages: 2329 - 2339
The Effects of Mobile-App-Based Low-Carbohydrate Dietary Guidance on Postprandial Hyperglycemia in Adults with Prediabetes Xiaoyu ChenHaihua SuQi Guo Original Research Open access 01 September 2020 Pages: 2341 - 2355
Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis Thomas WilkeSabrina MuellerMalgorzata Cel Original Research Open access 02 September 2020 Pages: 2357 - 2370
Effect of Dipeptidyl Peptidase 4 Inhibitors Used in Combination with Insulin Treatment in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis Jin YangQing TianTianpei Hong Original Research Open access 02 September 2020 Pages: 2371 - 2382
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes Kristina S. BoyeHélène SapinKirsi Norrbacka Original Research Open access 03 September 2020 Pages: 2383 - 2399
Decreased Muscle Strength of Knee Flexors is Associated with Impaired Muscle Insulin Sensitivity in Non-Diabetic Middle-Aged Japanese Male Subjects Yuki SomeyaYoshifumi TamuraHirotaka Watada Brief Report Open access 07 August 2020 Pages: 2401 - 2410
Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program—Results from a Comparative Effectiveness Trial Kelly N. B. PalmerValene E. Garr BarryTamara S. Hannon Brief Report Open access 08 August 2020 Pages: 2411 - 2418
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency Annaswamy RajiZhi Jin XuSamuel S. Engel Brief Report Open access 27 August 2020 Pages: 2419 - 2428
GLP-1RAs and SGLT2is Reduce Cardiovascular Events Independent of Reductions of Systolic Blood Pressure and Body Weight: A Meta-Analysis with Meta-Regression Mei QiuLiang-Liang DingHua Huang Brief Report Open access 27 August 2020 Pages: 2429 - 2440
Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment Toshiyuki Iwahori Letter Open access 07 August 2020 Pages: 2441 - 2442
Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment” Anne B. BrooksJakob LangerElizabeth D. Bacci Letter Open access 07 August 2020 Pages: 2443 - 2446